Pharmacopoeial Quality Requirements for Compounded Pharmaceuticals: Present and Future
- 作者: Shishova L.I.1, Sakanyan E.I.1, Shemeryankina T.B.1, Gubareva O.N.1
-
隶属关系:
- Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
- 期: 卷 51, 编号 8 (2017)
- 页面: 731-734
- 栏目: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244778
- DOI: https://doi.org/10.1007/s11094-017-1683-3
- ID: 244778
如何引用文章
详细
Issues related to regulation of the quality of compounded medicinal preparations by the State Pharmacopoeia of the Russian Federation are considered. Topical questions of the development and implementation of both general clauses and particular monographs related to compounded pharmaceuticals in national pharmacopoeial science and practice are discussed.
作者简介
L. Shishova
Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: chem@folium.ru
俄罗斯联邦, 8/2 Petrovskii Blvd., Moscow, 127051
E. Sakanyan
Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: chem@folium.ru
俄罗斯联邦, 8/2 Petrovskii Blvd., Moscow, 127051
T. Shemeryankina
Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: chem@folium.ru
俄罗斯联邦, 8/2 Petrovskii Blvd., Moscow, 127051
O. Gubareva
Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: chem@folium.ru
俄罗斯联邦, 8/2 Petrovskii Blvd., Moscow, 127051
补充文件
